Files in this item
Long Covid in adults discharged from UK hospitals after Covid-19 : a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
Item metadata
dc.contributor.author | Sigfrid, Louise | |
dc.contributor.author | Drake, Thomas M | |
dc.contributor.author | Pauley, Ellen | |
dc.contributor.author | Jesudason, Edwin C | |
dc.contributor.author | Olliaro, Piero | |
dc.contributor.author | Lim, Wei Shen | |
dc.contributor.author | Gillesen, Annelies | |
dc.contributor.author | Berry, Colin | |
dc.contributor.author | Lowe, David J | |
dc.contributor.author | McPeake, Joanne | |
dc.contributor.author | Lone, Nazir | |
dc.contributor.author | Munblit, Daniel | |
dc.contributor.author | Cevik, Muge | |
dc.contributor.author | Casey, Anna | |
dc.contributor.author | Bannister, Peter | |
dc.contributor.author | Russell, Clark D | |
dc.contributor.author | Goodwin, Lynsey | |
dc.contributor.author | Ho, Antonia | |
dc.contributor.author | Turtle, Lance | |
dc.contributor.author | O'Hara, Margaret E | |
dc.contributor.author | Hastie, Claire | |
dc.contributor.author | Donohue, Chloe | |
dc.contributor.author | Spencer, Rebecca G | |
dc.contributor.author | Donegan, Cara | |
dc.contributor.author | Gummery, Alison | |
dc.contributor.author | Harrison, Janet | |
dc.contributor.author | Hardwick, Hayley E | |
dc.contributor.author | Hastie, Claire E | |
dc.contributor.author | Carson, Gail | |
dc.contributor.author | Merson, Laura | |
dc.contributor.author | Baillie, J Kenneth | |
dc.contributor.author | Openshaw, Peter | |
dc.contributor.author | Harrison, Ewen M | |
dc.contributor.author | Docherty, Annemarie B | |
dc.contributor.author | Semple, Malcolm G | |
dc.contributor.author | Scott, Janet T | |
dc.contributor.author | ISARIC global follow-up working group | |
dc.contributor.author | ISARIC4C investigators | |
dc.date.accessioned | 2021-09-10T11:30:15Z | |
dc.date.available | 2021-09-10T11:30:15Z | |
dc.date.issued | 2021-09 | |
dc.identifier | 275695982 | |
dc.identifier | e06c42b0-d751-46ec-8a7d-4db64590cc98 | |
dc.identifier | 85112627608 | |
dc.identifier | 000704988300016 | |
dc.identifier.citation | Sigfrid , L , Drake , T M , Pauley , E , Jesudason , E C , Olliaro , P , Lim , W S , Gillesen , A , Berry , C , Lowe , D J , McPeake , J , Lone , N , Munblit , D , Cevik , M , Casey , A , Bannister , P , Russell , C D , Goodwin , L , Ho , A , Turtle , L , O'Hara , M E , Hastie , C , Donohue , C , Spencer , R G , Donegan , C , Gummery , A , Harrison , J , Hardwick , H E , Hastie , C E , Carson , G , Merson , L , Baillie , J K , Openshaw , P , Harrison , E M , Docherty , A B , Semple , M G , Scott , J T , ISARIC global follow-up working group & ISARIC4C investigators 2021 , ' Long Covid in adults discharged from UK hospitals after Covid-19 : a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol ' , The Lancet Regional Health - Europe , vol. 8 , 100186 . https://doi.org/10.1016/j.lanepe.2021.100186 | en |
dc.identifier.issn | 2666-7762 | |
dc.identifier.other | RIS: urn:E66DB718D1D310BBBACF9CAF750799EE | |
dc.identifier.other | ORCID: /0000-0003-1133-3874/work/99466510 | |
dc.identifier.uri | https://hdl.handle.net/10023/23939 | |
dc.description | Funding: This work is supported by grants from: the National Institute for Health Research (NIHR) [award CO-CIN-01], the Medical Research Council [grant MC_PC_19059], the Imperial Biomedical Research Centre (NIHR Imperial BRC, grant P45058), the Health Protection Research Unit (HPRU) in Respiratory Infections at Imperial College London and NIHR HPRU in Emerging and Zoonotic Infections at University of Liverpool, both in partnership with Public Health England, [NIHR award 200907], Wellcome Trust and Department for International Development [215091/Z/18/Z], and the Bill and Melinda Gates Foundation [OPP1209135], and Liverpool Experimental Cancer Medicine Centre (Grant Reference: C18616/A25153), NIHR Biomedical Research Centre at Imperial College London [IS-BRC-1215-20013], EU Platform for European Preparedness Against (Re-) emerging Epidemics 1 [FP7 project 602525] and NIHR Clinical Research Network for providing infrastructure support for this research. LT is a Wellcome Trust clinical career development fellow, supported by grant number 205228/Z/16/Z. This research was funded in part, by the Wellcome Trust. PJMO is supported by a NIHR Senior Investigator Award [award 201385]. | en |
dc.description.abstract | Background : This study sought to establish the long-term effects of Covid-19 following hospitalisation. Methods : 327 hospitalised participants, with SARS-CoV-2 infection were recruited into a prospective multicentre cohort study at least 3 months post-discharge. The primary outcome was self-reported recovery at least ninety days after initial Covid-19 symptom onset. Secondary outcomes included new symptoms, disability (Washington group short scale), breathlessness (MRC Dyspnoea scale) and quality of life (EQ5D-5L). Findings : 55% of participants reported not feeling fully recovered. 93% reported persistent symptoms, with fatigue the most common (83%), followed by breathlessness (54%). 47% reported an increase in MRC dyspnoea scale of at least one grade. New or worse disability was reported by 24% of participants. The EQ5D-5L summary index was significantly worse following acute illness (median difference 0.1 points on a scale of 0 to 1, IQR: -0.2 to 0.0). Females under the age of 50 years were five times less likely to report feeling recovered (adjusted OR 5.09, 95% CI 1.64 to 15.74), were more likely to have greater disability (adjusted OR 4.22, 95% CI 1.12 to 15.94), twice as likely to report worse fatigue (adjusted OR 2.06, 95% CI 0.81 to 3.31) and seven times more likely to become more breathless (adjusted OR 7.15, 95% CI 2.24 to 22.83) than men of the same age. Interpretation : Survivors of Covid-19 experienced long-term symptoms, new disability, increased breathlessness, and reduced quality of life. These findings were present in young, previously healthy working age adults, and were most common in younger females. | |
dc.format.extent | 13 | |
dc.format.extent | 1578651 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Lancet Regional Health - Europe | en |
dc.subject | Covid-19 | en |
dc.subject | Long-Covid | en |
dc.subject | Long-term outcomes | en |
dc.subject | Post-Covid | en |
dc.subject | Post-acute Covid-19 | en |
dc.subject | Quality of life | en |
dc.subject | Sequelae | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | 3rd-DAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | RA0421 | en |
dc.title | Long Covid in adults discharged from UK hospitals after Covid-19 : a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Infection and Global Health Division | en |
dc.identifier.doi | 10.1016/j.lanepe.2021.100186 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.